Treated by Dr. Ravi Chandra Reddy Obili at Dr Ravi Chandra Reddy
Multidisciplinary Hepatobiliary Cancer Care in Visakhapatnam involves coordinated treatment of cancers affecting the liver, bile ducts, and gallbladder through a team-based approach. This comprehensive care model integrates surgical oncology, medical oncology, radiation oncology, and interventional radiology to optimize patient outcomes. Dr Ravi Chandra Reddy Obili provides expert surgical management as part of this multidisciplinary team approach.
Primary liver cancer arising from hepatocytes, often associated with chronic liver disease, cirrhosis, or viral hepatitis. Requires specialized surgical and oncological management.
Cancer arising from bile duct epithelium, classified as intrahepatic or extrahepatic. Presents unique surgical challenges requiring expert hepatobiliary surgical skills.
Aggressive malignancy of the gallbladder, often diagnosed at advanced stages. Requires extended surgical resection including liver segments and lymph node dissection.
Multiple factors can contribute to the development and progression of this condition.
Multidisciplinary Hepatobiliary Cancer Care develops gradually. Recognising symptoms early gives you more treatment options.
From conservative to surgical — we always start with the least invasive option first.
A structured, patient-first approach from first visit to full recovery.
Dr Ravi Chandra Reddy Obili presents each case to a multidisciplinary team including medical oncologists, radiation oncologists, radiologists, and pathologists to formulate an individualized treatment plan based on tumor stage, liver function, and patient factors.
Detailed evaluation includes high-resolution CT/MRI imaging, liver function tests, tumor markers, and volumetric assessment of future liver remnant. Nutritional optimization and management of underlying liver disease are prioritized before surgery.
Dr Ravi Chandra Reddy Obili performs advanced hepatobiliary resections using modern surgical techniques, ensuring adequate oncological margins while preserving maximum liver function. Intraoperative ultrasound guides precise resection planning.
Coordinated follow-up includes surveillance imaging, adjuvant therapy when indicated, management of complications, and regular tumor board discussions. Long-term monitoring ensures early detection of recurrence and optimal quality of life.
What to expect at each phase of recovery.
Hospital stay of 7-14 days with intensive monitoring in specialized surgical unit. Focus on liver function recovery, bile leak prevention, and nutritional support. Drain management and early mobilization are prioritized.
Weeks 2-8 involve gradual return to activities with ongoing nutritional support. Adjuvant chemotherapy or radiation may commence 4-6 weeks post-surgery based on pathology. Regular follow-up with surgical and oncology teams continues.
Ongoing monitoring with CT/MRI scans every 3-6 months and tumor marker surveillance. Multidisciplinary team reviews ensure comprehensive care. Liver function is monitored and quality of life optimization continues throughout survivorship.
Complete tumor removal with negative margins provides the best chance for long-term survival, with 5-year survival rates ranging from 30-60% depending on cancer type and stage at presentation.
For unresectable cases, locoregional therapies and systemic treatments can achieve meaningful disease control, symptom relief, and improved quality of life with extended survival.
Careful surgical planning and technique preserve adequate liver remnant function, allowing patients to maintain normal liver physiology and reducing risk of post-hepatectomy liver failure.
Coordinated team approach ensures optimal treatment sequencing, reduces complications, improves treatment adherence, and provides comprehensive support throughout the cancer journey.
Untreated hepatobiliary cancers progress rapidly with median survival of 6-12 months depending on tumor type. Progressive liver failure, biliary obstruction, cachexia, and cancer-related complications significantly impact quality of life. Early intervention through multidisciplinary care offers the best opportunity for cure or meaningful disease control.
Seek immediate evaluation if you experience persistent jaundice, unexplained weight loss exceeding 5 kg, persistent right upper abdominal pain, or palpable abdominal mass. Patients with chronic liver disease, hepatitis B/C, or primary sclerosing cholangitis should undergo regular surveillance imaging. Early detection through multidisciplinary assessment significantly improves treatment outcomes.
Early treatment means more options and better outcomes. Book a consultation to understand your condition and explore the right path forward.
